Determinants of cardiovascular risk in current rheumatic practice

Inger Louise Meek

Research output: ThesisPhD Thesis - Research UT, graduation UT

232 Downloads (Pure)


The aim of this thesis was to study cardiovascular risk in arthritis: Firstly, how do different rheumatic diseases compare in the patients’ traditional cardiovascular (CV) risk factor profiles, and does this justify the general focus on rheumatoid arthritis regarding cardiovascular complications in rheumatic practice? Secondly, can we identify rheumatic disease specific factors, such as biomarkers, disease characteristics or treatment factors, that are associated with increased or decreased cardiovascular risk? Thirdly, does cardiovascular damage, manifesting itself through the occurrence of cardiovascular events, also occur if rheumatic disease is tightly controlled and average rheumatic inflammatory activity is low? And finally, what is the contribution of non steroidal anti-inflammatory drug (NSAID) use to excess cardiovascular events in rheumatic patients? For this purpose we initiated the Arthritis Center Twente CardioVascular Disease (ACTCVD) cohort and performed an ex vivo pharmacodynamic experiment, the results of which are presented in this thesis.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • University of Twente
  • van de Laar, Mart A.F.J., Supervisor
  • Vonkeman, Harald E., Advisor
Award date21 Mar 2014
Place of PublicationEnschede
Print ISBNs978-94-6108-617-4
Publication statusPublished - 21 Mar 2014


Dive into the research topics of 'Determinants of cardiovascular risk in current rheumatic practice'. Together they form a unique fingerprint.

Cite this